Tier
Species
Size
Attr.
GeneSet
Tier II
423
GS129191: seizure susceptibility 2 (Szs2 Published QTL Chr 4)
Figure Label:
QTL-Szs2-Mouse-Chr 4
Description:
QTL associated with seizure susceptibility 2. The confidence interval is Chr4:94736033-28006254 bp,+strand
Authors:
Ferraro TN, Golden GT, Smith GG, Schork NJ, St Jean P, Ballas C, Choi H, Berrettini WH
Tier II
853
GS129123: cataract severity (Ctrcts Published QTL Chr 4)
Figure Label:
QTL-Ctrcts-Mouse-Chr 4
Description:
QTL associated with cataract severity. The confidence interval is Chr4:45722797-138171357 bp,+strand
Authors:
Wolf N, Galecki A, Lipman R, Chen S, Smith-Wheelock M, Burke D, Miller R
Tier II
524
GS129184: skin tumor susceptibility in FVB and PWK 1 (Skts-fp1 Published QTL Chr 4)
Figure Label:
QTL-Skts-fp1-Mouse-Chr 4
Description:
QTL associated with skin tumor susceptibility in FVB and PWK 1. The confidence interval is Chr4:53563711-123838630 bp,+strand
Authors:
Fujiwara K, Igarashi J, Irahara N, Kimura M, Nagase H
Tier II
423
GS129188: spermatogenesis defect 1 (Spmd1 Published QTL Chr 4)
Figure Label:
QTL-Spmd1-Mouse-Chr 4
Description:
QTL associated with spermatogenesis defect 1. The confidence interval is Chr4:94736033-28006254 bp,+strand
Authors:
Bolor H, Wakasugi N, Zhao WD, Ishikawa A
Tier II
329
GS136067: immune response to AAV2 QTL 1 (Imraq1, Published QTL Chr 4)
Figure Label:
QTL-Imraq1-Mouse-Chr 4
Description:
QTL associated with immune response to AAV2 QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (59415112)
Authors:
Zhang HG, High KA, Wu Q, Yang P, Schlachterman A, Yu S, Yi N, Hsu HC, Mountz JD
Tier II
327
GS136231: mandible length 5 (Manln5, Published QTL Chr 4)
Figure Label:
QTL-Manln5-Mouse-Chr 4
Description:
QTL associated with mandible length 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (63026328)
Authors:
Cheverud JM, Ehrich TH, Vaughn TT, Koreishi SF, Linsey RB, Pletscher LS
Tier II
327
GS136262: modifier of mammary tumor growth 1 (Mmtg1, Published QTL Chr 4)
Figure Label:
QTL-Mmtg1-Mouse-Chr 4
Description:
QTL associated with modifier of mammary tumor growth 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (63026328)
Authors:
Le Voyer T, Rouse J, Lu Z, Lifsted T, Williams M, Hunter KW
Tier II
267
GS136776: synechia 2 (Synch2, Published QTL Chr 4)
Figure Label:
QTL-Synch2-Mouse-Chr 4
Description:
QTL associated with synechia 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (76872944)
Authors:
Wolf N, Galecki A, Lipman R, Chen S, Smith-Wheelock M, Burke D, Miller R
Tier II
313
GS135283: "alcohol preference locus 7, male specific" (Alcp7, Published QTL Chr 4)
Figure Label:
QTL-Alcp7-Mouse-Chr 4
Description:
QTL associated with "alcohol preference locus 7, male specific". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (34342409)
Authors:
Gill K, Desaulniers N, Desjardins P, Lake K
Tier II
313
GS135284: "alcohol preference locus 8, female specific" (Alcp8, Published QTL Chr 4)
Figure Label:
QTL-Alcp8-Mouse-Chr 4
Description:
QTL associated with "alcohol preference locus 8, female specific". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (34342409)
Authors:
Gill K, Desaulniers N, Desjardins P, Lake K
Tier II
334
GS135709: diabetes susceptibility QTL 6 (Dbsq6, Published QTL Chr 4)
Figure Label:
QTL-Dbsq6-Mouse-Chr 4
Description:
QTL associated with diabetes susceptibility QTL 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (55263802)
Authors:
Moritani M, Togawa K, Yaguchi H, Fujita Y, Yamaguchi Y, Inoue H, Kamatani N, Itakura M
Tier II
335
GS136230: mandible length 4 (Manln4, Published QTL Chr 4)
Figure Label:
QTL-Manln4-Mouse-Chr 4
Description:
QTL associated with mandible length 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (53324953)
Authors:
Cheverud JM, Ehrich TH, Vaughn TT, Koreishi SF, Linsey RB, Pletscher LS
Tier II
335
GS136287: modifier of polycystic kidney disease progression 1 (Mopkd1, Published QTL Chr 4)
Figure Label:
QTL-Mopkd1-Mouse-Chr 4
Description:
QTL associated with modifier of polycystic kidney disease progression 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (53563711)
Authors:
Woo DD, Nguyen DK, Khatibi N, Olsen P
Tier II
333
GS136744: spermatogenesis defect 2 (Spmd2, Published QTL Chr 4)
Figure Label:
QTL-Spmd2-Mouse-Chr 4
Description:
QTL associated with spermatogenesis defect 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (46492110)
Authors:
Bolor H, Wakasugi N, Zhao WD, Ishikawa A
Tier II
332
GS136775: synechia 1 (Synch1, Published QTL Chr 4)
Figure Label:
QTL-Synch1-Mouse-Chr 4
Description:
QTL associated with synechia 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (45722797)
Authors:
Wolf N, Galecki A, Lipman R, Chen S, Smith-Wheelock M, Burke D, Miller R
Tier IV
51914
GS405734: WWP1 KO vs WT
Figure Label:
WWP1
Description:
To see gene sets category
Authors:
Tier II
423
GS129071: anticardiolipin antibody 2 (Acla2 Published QTL Chr 4)
Figure Label:
QTL-Acla2-Mouse-Chr 4
Description:
QTL associated with anticardiolipin antibody 2. The confidence interval is Chr4:94736033-28006254 bp,+strand
Authors:
Ida A, Hirose S, Hamano Y, Kodera S, Jiang Y, Abe M, Zhang D, Nishimura H, Shirai T
Tier II
423
GS129177: splenomegaly-NZB x NZW 2 (Sbw2 Published QTL Chr 4)
Figure Label:
QTL-Sbw2-Mouse-Chr 4
Description:
QTL associated with splenomegaly-NZB x NZW 2. The confidence interval is Chr4:94736033-28006254 bp,+strand
Authors:
Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN
Tier II
423
GS129186: silicosis susceptibility 1 (Slcs1 Published QTL Chr 4)
Figure Label:
QTL-Slcs1-Mouse-Chr 4
Description:
QTL associated with silicosis susceptibility 1. The confidence interval is Chr4:94736033-28006254 bp,+strand
Authors:
Ohtsuka Y, Wang XT, Saito J, Ishida T, Munakata M
Tier II
330
GS129083: atherosclerosis 8 (Ath8 Published QTL Chr 4)
Figure Label:
QTL-Ath8-Mouse-Chr 4
Description:
QTL associated with atherosclerosis 8. The confidence interval is Chr4:45671314-104972403 bp,+strand
Authors:
Wang SS, Shi W, Wang X, Velky L, Greenlee S, Wang MT, Drake TA, Lusis AJ
Tier II
314
GS129092: bone mechanical trait 2 (Bmch2 Published QTL Chr 4)
Figure Label:
QTL-Bmch2-Mouse-Chr 4
Description:
QTL associated with bone mechanical trait 2. The confidence interval is Chr4:45722797-102244445 bp,+strand
Authors:
Volkman SK, Galecki AT, Burke DT, Miller RA, Goldstein SA
Tier II
327
GS135409: body growth late QTL 4 (Bglq4, Published QTL Chr 4)
Figure Label:
QTL-Bglq4-Mouse-Chr 4
Description:
QTL associated with body growth late QTL 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (63026328)
Authors:
Brown AC, Olver WI, Donnelly CJ, May ME, Naggert JK, Shaffer DJ, Roopenian DC
Tier II
327
GS135446: bone length and organs 2 (Bod2, Published QTL Chr 4)
Figure Label:
QTL-Bod2-Mouse-Chr 4
Description:
QTL associated with bone length and organs 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (63026328)
Authors:
Kenney-Hunt JP, Vaughn TT, Pletscher LS, Peripato A, Routman E, Cothran K, Durand D, Norgard E, Perel C, Cheverud JM
Tier II
329
GS135467: blood pressure QTL 3 (Bpq3, Published QTL Chr 4)
Figure Label:
QTL-Bpq3-Mouse-Chr 4
Description:
QTL associated with blood pressure QTL 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (59415112)
Authors:
Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B
Tier II
326
GS135525: body weight QTL 9 (Bwtq9, Published QTL Chr 4)
Figure Label:
QTL-Bwtq9-Mouse-Chr 4
Description:
QTL associated with body weight QTL 9. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (59565384)
Authors:
Stylianou IM, Korstanje R, Li R, Sheehan S, Paigen B, Churchill GA